Baltimore, MD, United States of America

Robert J Spence

This inventor holds 1 USPTO granted patent. Top assignee: Collagenix Corporation. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert J Spence

Introduction

Robert J Spence is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical devices, particularly in the area of breast prosthetics. His innovative approach has led to the development of a unique breast prosthesis that enhances biocompatibility for patients.

Latest Patents

Spence holds a patent for a breast prosthesis with improved biocompatibility and a method of making it. This single lumen implantable prosthesis is composed of an outer membrane made of silastic, medical-grade silicone. The inner filling material is selected from purified reconstituted collagen gel and a purified gel of poly-alpha amino acid homopolymers or random copolymers, with a molecular weight ranging from 5,000 to 400,000. The purified reconstituted collagen gel has a collagen concentration of 20 to 100 milligrams per milliliter of gel.

Career Highlights

Throughout his career, Robert J Spence has been associated with Collagenix Corporation, where he has focused on advancing medical technologies. His work has been instrumental in improving the quality of life for individuals requiring breast prosthetics.

Collaborations

Spence collaborates with Steven R Jefferies, contributing to the innovative projects at Collagenix Corporation. Their combined expertise has fostered advancements in the field of biocompatible medical devices.

Conclusion

Robert J Spence's contributions to the field of breast prosthetics exemplify the impact of innovation in medical technology. His patented designs and collaborative efforts continue to pave the way for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…